Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Kyker-Snowman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2017
Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma ComponentBracha Erlanger Avigdor, Katie Beierl, Christopher D Gocke, et al.
Breast Cancer Research and Treatment|February 13, 2017
PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
Breast Cancer Research and Treatment|December 12, 2019
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic propertiesKelly Kyker-Snowman, Robert M Hughes, Christopher L Yankaskas, et al.
NPJ Breast Cancer|April 24, 2021
Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor developmentYanying Huo, Pier Selenica, Amar H Mahdi, et al.
Breast Cancer Research and Treatment|December 19, 2018
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapiesBerry Button, Sarah Croessmann, David Chu, et al.
Oncotarget|February 21, 2022
<i>NOTCH1</i> PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer modelKaren Cravero, Morgan V Pantone, Dong Ho Shin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stabilitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
The Journal of Clinical Investigation|February 2, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclonesSwathi Karthikeyan, Ian G Waters, Lauren Dennison, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
HER2 missense mutations have distinct effects on oncogenic signaling and migrationDaniel J Zabransky, Christopher L Yankaskas, Rory L Cochran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2017
Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma ComponentBracha Erlanger Avigdor, Katie Beierl, Christopher D Gocke, et al.
Breast Cancer Research and Treatment|February 13, 2017
PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
Breast Cancer Research and Treatment|December 12, 2019
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic propertiesKelly Kyker-Snowman, Robert M Hughes, Christopher L Yankaskas, et al.
NPJ Breast Cancer|April 24, 2021
Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor developmentYanying Huo, Pier Selenica, Amar H Mahdi, et al.
Breast Cancer Research and Treatment|December 19, 2018
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapiesBerry Button, Sarah Croessmann, David Chu, et al.
Oncotarget|February 21, 2022
<i>NOTCH1</i> PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer modelKaren Cravero, Morgan V Pantone, Dong Ho Shin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stabilitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
The Journal of Clinical Investigation|February 2, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclonesSwathi Karthikeyan, Ian G Waters, Lauren Dennison, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
HER2 missense mutations have distinct effects on oncogenic signaling and migrationDaniel J Zabransky, Christopher L Yankaskas, Rory L Cochran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Pageof 2